74 results
Page 2 of 4
8-K
1ggxqe27
29 Jun 23
Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US
8:30am
8-K
EX-99.1
8xx1fuitza7v lkkui
29 Jun 23
Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US
8:30am
424B5
7zaaziba
28 Jun 23
Prospectus supplement for primary offering
7:14am
424B5
muavh
5 Jun 23
Prospectus supplement for primary offering
5:21pm
424B5
k3hndji3
24 May 23
Prospectus supplement for primary offering
11:15am
424B5
h2xh owoy
23 May 23
Prospectus supplement for primary offering
12:55pm
8-K
EX-99.1
6w3bra9oh4o fxs4tmx
22 May 23
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
8:30am
8-K
mnfuj
22 May 23
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
8:30am
8-K
91ycuh6nq93eb7yx
3 May 23
Regulation FD Disclosure
9:00am
8-K
EX-99.1
pv97h p4c
3 May 23
Regulation FD Disclosure
9:00am
424B5
jvf8kd
24 Oct 22
Prospectus supplement for primary offering
4:30pm
8-K
0upz2s tuz8y72
13 Oct 22
Microbot Medical Completes GLP Animal Study for the LIBERTY® Robotic System
9:34am
8-K
EX-99.1
wjpx6h wh6
13 Oct 22
Microbot Medical Completes GLP Animal Study for the LIBERTY® Robotic System
9:34am
8-K
0w6g ijeuecubmncx
6 Apr 22
Microbot Medical Continues to Strengthen Management Team as Rachel Vaknin Promoted to Chief Financial Officer
4:05pm
8-K
EX-10.1
aiveplrw1
6 Apr 22
Microbot Medical Continues to Strengthen Management Team as Rachel Vaknin Promoted to Chief Financial Officer
4:05pm
424B5
z9zbkg4
10 Jun 21
Prospectus supplement for primary offering
5:30pm